Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

This study has been terminated.

( Enrollment suspended based upon interim analysis; subjects allowed to stay on study until disease progression. )

Study NCT00061646 Information provided by Abbott

First Received: June 2, 2003 Last Updated: August 10, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given